ALMR Alamar Biosciences, Inc. - Class A common stock
$34,83
Harga · Agu 19, 2026
Fundamental per Agu 11, 2026
Rentang 52M
$19–$39
81% of range
Peringkat Analis
BUY
11 analysts
Target Harga
$33
P/E (TTM)
—
ROE
—
Margin Laba Bersih
—
ALMR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$34.83
Kapitalisasi Pasar
—
P/E (TTM)
—
EPS (TTM)
—
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
—
D/E Utang/Ekuitas
—
Rentang 52M
$19 – $39
ALMR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
—
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
ALMR
Median Rekan
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
ALMR
Median Rekan
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
ALMR
Median Rekan
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
ALMR
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
ALMR
Median Rekan
ALMR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
11 analis
- Beli Kuat 4 36,4%
- Beli 5 45,5%
- Tahan 2 18,2%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
5 analis · 2026-08-19
Median
$34.00
Rata-rata
$33.40
Sekarang
$34.83
Rendah
$31.00
Tinggi
$35.00
Target median
$34.00
-2,4%
Target rata-rata
$33.40
-4,1%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.11%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-0.22 | $-0.33 | 0.11% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ALMR | — | — | — | — | — | — |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
| ADPT | $2.50B | -41.6 | 54.8% | -21.5% | -28.2% | — |
| BLFS | — | -241.8 | 28.9% | — | — | — |
| FTRE | $1.61B | -1.6 | 1.0% | -36.2% | -171.1% | — |
| PSNL | $816M | -8.7 | -17.7% | -116.7% | -36.0% | — |
| MRVI | — | -3.6 | -28.3% | -70.4% | -48.6% | 18.3% |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Neraca 20
| Metrik | Tren | 2025 |
|---|---|---|
| Cash & Equivalents | $30M | |
| Short-term Investments | $0 | |
| Receivables | $13M | |
| Inventory | $38M | |
| Prepaid Expense | $13M | |
| Current Assets | $95M | |
| PP&E (Net) | $10M | |
| Other Non-current Assets | $2M | |
| Total Assets | $140M | |
| Accounts Payable | $6M | |
| Current Liabilities | $24M | |
| Capital Leases | $30M | |
| Other Non-current Liabilities | $599.0K | |
| Total Liabilities | $64M | |
| Common Stock | $1.0K | |
| Paid-in Capital | $10M | |
| Retained Earnings | $-169M | |
| AOCI | $-72.0K | |
| Stockholders' Equity | $-159M | |
| Liabilities + Equity | $140M |
Laporan Laba Rugi 16
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Revenue | $29M | $26M | $16M | $13M | |
| Cost of Revenue | $12M | $12M | $8M | $7M | |
| Gross Profit | $18M | $14M | $9M | $6M | |
| R&D Expense | $14M | $13M | $9M | $8M | |
| SG&A Expense | $17M | $14M | $8M | $7M | |
| Operating Expenses | $31M | $27M | $16M | $15M | |
| Operating Income | $-14M | $-12M | $-8M | $-9M | |
| Interest Income | $2M | $539.0K | $630.0K | $786.0K | |
| Pretax Income | $-13M | $-21M | $-7M | $-8M | |
| Income Tax | $-93.0K | $464.0K | · | · | |
| Net Income | $-13M | $-21M | $-7M | $-8M | |
| EPS (Basic) | $-0.22 | $-1.74 | $-0.62 | $-0.68 | |
| EPS (Diluted) | $-0.22 | $-1.74 | $-0.62 | $-0.68 | |
| Shares (Basic) | 58,665,055 | 12,259,811 | 11,409,556 | 11,258,870 | |
| Shares (Diluted) | 58,665,055 | 12,259,811 | 11,409,556 | 11,258,870 | |
| EBITDA | $-14M | $-12M | · | · |
Neraca 20
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $133M | $65M | · | · | |
| Short-term Investments | $117M | $0 | · | · | |
| Receivables | $20M | $20M | · | · | |
| Inventory | $45M | $40M | · | · | |
| Prepaid Expense | $16M | $17M | · | · | |
| Current Assets | $331M | $141M | · | · | |
| PP&E (Net) | $13M | $10M | · | · | |
| Other Non-current Assets | $3M | $2M | · | · | |
| Total Assets | $391M | $186M | · | · | |
| Accounts Payable | $14M | $6M | · | · | |
| Current Liabilities | $28M | $24M | · | · | |
| Capital Leases | $39M | $29M | · | · | |
| Other Non-current Liabilities | $1M | $1M | · | · | |
| Total Liabilities | $78M | $130M | · | · | |
| Common Stock | $7.0K | $1.0K | · | · | |
| Paid-in Capital | $516M | $12M | · | · | |
| Retained Earnings | $-203M | $-190M | · | · | |
| AOCI | $-139.0K | $-80.0K | · | · | |
| Stockholders' Equity | $313M | $-178M | · | · | |
| Liabilities + Equity | $391M | $186M | · | · |
Arus Kas 8
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| D&A | $1M | $1M | $919.0K | $888.0K | |
| Stock-based Comp | $3M | $1M | $680.0K | $619.0K | |
| Operating Cash Flow | $-11M | $-20M | $-12M | $-13M | |
| CapEx | $4M | $600.0K | $753.0K | $554.0K | |
| Investing Cash Flow | $-121M | $-778.0K | $18M | $17M | |
| Financing Cash Flow | $202M | $56M | $164.0K | $243.0K | |
| Net Change in Cash | $70M | $35M | $7M | $4M | |
| Free Cash Flow | · | $-21M | · | · |
Profitabilitas 8
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Gross Margin | 60.2% | 55.5% | · | · | |
| Operating Margin | -46.0% | -47.4% | · | · | |
| Net Margin | -44.9% | -81.9% | · | · | |
| Pretax Margin | -45.2% | -80.1% | · | · | |
| EBITDA Margin | -46.0% | -47.4% | · | · | |
| ROA | -6.8% | -22.9% | · | · | |
| ROE | -8.4% | 23.9% | · | · | |
| ROIC | -4.3% | 7.1% | · | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | 11.9 | 5.9 | · | · | |
| Quick Ratio | 9.7 | 3.5 | · | · |
Efisiensi 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | · | · | |
| Inventory Turnover | 0.5 | 0.6 | · | · | |
| Receivables Turnover | 2.9 | 2.7 | · | · |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Sands Capital Life Sciences Pulse Fund II, L.P., Sands Capital Alternatives, LLC, SANDS FRANK M. ×2 pengajuan | 7 Juli 2026 | 6,10% | Amandemen | — | SEC |
| Illumina Innovation Fund II GP, L.L.C., Illumina Innovation Fund II, L.P., Illumina Innovation Fund III GP, L.L.C., Illumina Innovation Fund III, L.P., Nicholas Naclerio | 23 April 2026 | 9,60% | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 10 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IWO · iShares Trust | 0,02% | 83.896 SH | 8 Agu 2026 | Harian |
| IWM · iShares Trust | 0,01% | 315.009 SH | 8 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 76.481 SH | 8 Agu 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3.607 SH | 8 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.862 SH | 8 Agu 2026 | Harian |
| IWN · iShares Trust | 0,01% | 35.607 SH | 8 Agu 2026 | Harian |
| ISCB · iShares Trust | 0,01% | 625 SH | 8 Agu 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 136.470 SH | 8 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 320.260 SH | 8 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.135 SH | 8 Agu 2026 | Harian |